Cargando…
Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
This opinion piece presents an approach to standardisation of an important aspect of Chagas disease drug discovery and development: selecting Trypanosoma cruzi strains for in vitro screening. We discuss the rationale for strain selection representing T. cruzi diversity and provide recommendations on...
Autores principales: | Zingales, Bianca, Miles, Michael A, Moraes, Carolina B, Luquetti, Alejandro, Guhl, Felipe, Schijman, Alejandro G, Ribeiro, Isabela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238778/ https://www.ncbi.nlm.nih.gov/pubmed/25317712 http://dx.doi.org/10.1590/0074-0276140156 |
Ejemplares similares
-
Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
por: Zingales, Bianca, et al.
Publicado: (2022) -
Future studies should consider multiple predisposing conditions in predicting weaning failure from mechanical ventilation in patients after cardiac surgery
por: Aydogan, Mehmet, et al.
Publicado: (2013) -
Autonomic dysfunction and beta blocker therapy in Chagas heart disease
por: Bestetti, Reinaldo B, et al.
Publicado: (2013) -
Certifying achievement in the control of Chagas disease native vectors:
what is a viable scenario?
por: Hashimoto, Ken, et al.
Publicado: (2014) -
Which device should be chosen for the percutaneous closure of post-traumatic ventricular septal defects?
por: Demirkol, Sait, et al.
Publicado: (2013)